AbstractHIVViral Hepatitis and Liver DiseaseA Comprehensive Molecular Epidemiological Analysis of SARS-CoV-2 Infection in Cyprus from April 2020 to January 2021: Evidence of a Highly Polyphyletic and Evolving EpidemicView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCharacterization of SARS-CoV-2 variants circulating in Central Italy by deep-sequencing of full-length S geneView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseHigh sensitivity pool testing for SARS-CoV-2 RNA from throat wash and nasopharyngeal swabsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseSignificant SARS-CoV-2 RNA decay during remdesivir treatment in real life COVID-19 hospitalized patientsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseNeutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workersView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseLong-acting HIV capsid inhibitor effective as PrEP in a SHIV rhesus macaque modelView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePrevalence of genotypic baseline risk factors of cabotegravir+rilpivirine failure among ARV-naïve patientsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseHIV-1 subtypes B, G and CRF02_AG transmission cluster in Migrants population followed in Portugal based on sequence dataView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseLow prevalence of archived M184V/I mutations in 3 HIV-1 suppressed, switch studiesView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseKinetics of archived M184V mutation in HIV-DNA from highly experienced HIV-infected patients with sustained viral suppressionView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseHIV-1 reverse transcriptase natural polymorphism V106I does not alter the susceptibility and the genetic barrier to resistance to Doravirine in vitro.View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseVirological efficacy of switch to 3TC/DTG in a real life cohort of suppressed HIV-1 patients with or without past M184V – The LAMRES StudyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseExploratory Analysis of Baseline Phenotypic and Genotypic Parameters in Relation to Antiviral Activity for Fostemsavir (FTR) in Heavily Treatment-Experienced (HTE) Patients in the Phase 3 BRIGHTE StudyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseDeterminants of HIV-1 late presentation in patients followed in EuropeView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseExploration of the possible mechanisms leading to greater mortality in people with limited drug options (LDO)View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseDynamics of total and intact HIV-1 DNA in virologically suppressed patients switching to DTG+3TC or ATV/r+3TC dual therapyView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseUsefulness of next-generation sequencing on PBMC samples and HIV-1 DNA quantification in management of treatment optimization in HIV-1 infected virologically suppressed individualsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAPOBEC editing in HIV DNA proviral vif and pol long-reads issued from virologically-suppressed patients included in the ANRS LAMIDOL trialView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseA Multi-Allelic Molecular-Beacon-Based Real-Time RT-PCR Assay for the Detection of the Coronavirus SARS-CoV-2 from Clinical SamplesView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseUse of Fibroquel® (type I polymerized collagen) in patients with hypoxemic inflammatory pneumonia secondary to COVID-19 in Veracruz, Mexico.View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseLongitudinal Evaluation of Sequencing Quality in EQA-Schemes from 2014 to 2020View Abstract
AbstractHIVViral Hepatitis and Liver DiseasePK-virological algorithm to target risk of resistance among key populations in TogoView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAssociation of APOBEC3 activity in HIV-1 DNA with non-B HIV-1 and low HIV-1 reservoirView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCharacterization of the newly proposed HIV-1 lineage within subtype A, sub-subtype A7View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseMolecular epidemiology and HIV-1 variant evolution in Poland between 2015 and 2019View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseEpidemiology and transmission of drug resistance mutations among treatment-naïve people living with HIV-1 in Israel, 2010-2018View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAssessment of HIV-1 DNA quantification methods in the Italian HIV DNA NetworkView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseNervous system pathology of HIV-positive people in the large industrial center within the Russian Federation: epidemiological analysisView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseAIDS mortality and lethality in Minsk, BelarusView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseCo-infections with hepatitis virus B and C among patients with human immunodeficiency virus in a regional center of HIV/AIDS from northeastern RomaniaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseMolecular Epidemiology Analysis Reveals Actively Growing Transmission Clusters in the Polyphyletic HIV-1 Infection in Cyprus (2019-2020)View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseHepatitis C virus treatment response to sofosbuvir/ledipasvir among adolescents coinfected with HIV and HCV: Real world data from UkraineView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePharmacist-led telephone clinic is an effective strategy for treating patients with hepatitis C and removing barriers to attending appointmentsView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseA Public Health Approach to Sustainability of Community Based HCV Treatment among HIV/HCV Co-infected KPs through programmatic cost efficiency in UkraineView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseHow Carbon Nanotubes can orchestrate the immunological response? Perspectives in vaccine applicationView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseFrequency of IN gene region polymorphisms associated with ALLINIs effectiveness in HIV-1 subtype A6 dominating in RussiaView Abstract
AbstractHIVViral Hepatitis and Liver DiseasePretreated drug-resistance in newly diagnosed HIV-1 patients in Portugal between 2014 and 2019View Abstract
AbstractHIVViral Hepatitis and Liver DiseaseApplication of the genetic diversity analysis for determination of HIV infection durationView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseIntegrase genotyping is highly effective on diverse HIV-1 non-B clades circulating in Cameroon: toward a successful transition to Dolutegravir-based regimens in AfricaView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseComparison of the new Cepheid HIV VL XC Assay with the established Abbott Alinity m in HIV-1 viral load measurementView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseSensitivity of ultra-deep sequencing for dual HIV infection detectionView Abstract
AbstractHIVViral Hepatitis and Liver DiseaseMolecular epidemiology of SARS-CoV-2 in Greece reveals low rates of onward virus transmission after lifting of travel restrictions based on risk assessment during summer 2020View Abstract
